Aurora Cannabis Inc. Common Shares (ACB) Stock Price

ACBStock

$3.99−24.09%52W

Market Cap$252.61M

P/E114.43x

PEG Ratio—

Div yield—

Beta1.72

ACB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)7.35%

Price vs S&P 500 (4W)5.77%

VGM Score51.44

P/E Ratio (Annual)114.43x

P/CF (Annual)16.22x

Book Value / Share (Quarterly)$5.89

P/TBV (Annual)0.54x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)22.37%

Cash Flow / Share (Quarterly)$-0.57

Price vs S&P 500 (YTD)-14.18%

Gross Margin (TTM)6.25%

Net Profit Margin (TTM)-38.12%

EPS (TTM)$-1.37

10-Day Avg Trading Volume0.44M

EPS Excl Extra (TTM)$-1.37

Revenue Growth (5Y)5.50%

EPS (Annual)$-1.52

ROI (Annual)-22.73%

Gross Margin (Annual)6.40%

Net Profit Margin (5Y Avg)-190.13%

Cash / Share (Quarterly)$1.12

Revenue Growth QoQ (YoY)-31.08%

P/E Normalized (Annual)114.43x

ROA (Last FY)-20.26%

Revenue Growth TTM (YoY)-18.93%

EBITD / Share (TTM)$-0.60

ROE (5Y Avg)-66.99%

Operating Margin (TTM)-17.62%

Cash Flow / Share (Annual)$-0.43

P/B Ratio0.72x

P/B Ratio (Quarterly)0.46x

Net Income / Employee (Annual)$-78,178

EV / Revenue (TTM)1.16x

Net Interest Coverage (TTM)-256.43x

ROA (TTM)-16.06%

EPS Growth QoQ (YoY)-94.35%

EV / EBITDA (TTM)25.29x

EPS Incl Extra (Annual)$-1.52

Current Ratio (Annual)5.94x

Quick Ratio (Quarterly)2.63x

3-Month Avg Trading Volume0.43M

52-Week Price Return-24.09%

Revenue / Employee (TTM)$186,257

Tangible BV / Share (Quarterly)$5.52

P/S Ratio (Annual)1.19x

Asset Turnover (Annual)0.53x

52-Week High$6.18

Operating Margin (5Y Avg)-187.49%

EPS Excl Extra (Annual)$-1.52

CapEx CAGR (5Y)-15.74%

Tangible BV CAGR (5Y)-22.06%

26-Week Price Return17.26%

Quick Ratio (Annual)3.16x

13-Week Price Return50.80%

Total Debt / Equity (Annual)0.05x

Current Ratio (Quarterly)5.36x

Enterprise Value$237.05M

Revenue / Share Growth (5Y)-17.17%

Asset Turnover (TTM)0.42x

Book Value / Share Growth (5Y)-39.01%

Revenue / Employee (Annual)$205,837

Inventory Turnover (Annual)1.45x

Pretax Margin (Annual)-17.63%

Cash / Share (Annual)$1.40

3-Month Return Std Dev66.40%

Gross Margin (5Y Avg)-10.51%

Net Income / Employee (TTM)$-70,968

ROE (Last FY)-23.79%

Net Interest Coverage (Annual)0.48x

EPS Basic Excl Extra (Annual)$-1.52

P/FCF (TTM)23.73x

Receivables Turnover (TTM)7.23x

Total Debt / Equity (Quarterly)0.04x

EPS Incl Extra (TTM)$-1.37

Receivables Turnover (Annual)8.33x

ROI (TTM)-18.78%

P/S Ratio (TTM)1.32x

Pretax Margin (5Y Avg)-184.07%

Revenue / Share (Annual)$4.00

Tangible BV / Share (Annual)$5.76

Forward P/E63.59x

Price vs S&P 500 (52W)-39.62%

Year-to-Date Return-2.25%

5-Day Price Return-12.15%

EPS Normalized (Annual)$-1.52

ROA (5Y Avg)-41.51%

Net Profit Margin (Annual)-37.98%

Month-to-Date Return1.44%

Cash Flow / Share (TTM)$-0.27

EBITD / Share (Annual)$-0.73

Operating Margin (Annual)-19.53%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-48.85%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.37

P/TBV (Quarterly)0.49x

P/B Ratio (Annual)0.51x

Inventory Turnover (TTM)1.31x

Pretax Margin (TTM)-14.05%

Book Value / Share (Annual)$6.14

Price vs S&P 500 (13W)48.12%

Beta1.72x

P/FCF (Annual)19098.87x

Revenue / Share (TTM)$3.32

ROE (TTM)-20.99%

52-Week Low$2.54

vGradeB

gGradeD

mGradeB

vgmGradeC

ACB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.15	-$0.05	+67.06%(+$0.10)
Q1 2026	Jun 11, 2026	-$0.10	-$0.70	-590.71%(-$0.60)
Q4 2025	Feb 4, 2026	-$0.06	$0.02	+135.29%(+$0.08)
Q3 2025	Nov 5, 2025	-$0.07	-$0.64	-810.00%(-$0.57)
Q2 2025	Aug 6, 2025	-$0.01	-$0.19	-1250.00%(-$0.18)

ACB Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.70

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About Aurora Cannabis Inc. Common Shares

Aurora Cannabis Inc is a Canadian cannabis producer headquartered in Edmonton that cultivates and sells medicinal and recreational cannabis products under brands including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. The company generates the majority of its revenue from the Canadian market while maintaining operations and medical cannabis export agreements across Europe and Australia. Its diversified brand portfolio supports both its core domestic market and growing international operations.